NanoViricides (NYSEMKT:NNVC) jumps 36% after hours in reaction to its announcement related to its development plans for a drug to treat COVID-19 infection.
Management intends to conduct initial testing of
its drug candidates in its own virology laboratory using low-threat
coronavirus strains that have been normally circulating in the human
population. If successful, it has the ability to make “kilogram
quantities” in just a few weeks which, it says, would be sufficient to
treat several hundred to a few thousand patients.
https://seekingalpha.com/news/3549208-nanoviricides-up-36-after-hours-on-coronavirus-drug-progress
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.